Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism

The computational study of human metabolism has been advanced with the advent of the first generic (non‐tissue specific) stoichiometric model of human metabolism. In this study, we present a new algorithm for rapid reconstruction of tissue‐specific genome‐scale models of human metabolism. The algorithm generates a tissue‐specific model from the generic human model by integrating a variety of tissue‐specific molecular data sources, including literature‐based knowledge, transcriptomic, proteomic, metabolomic and phenotypic data. Applying the algorithm, we constructed the first genome‐scale stoichiometric model of hepatic metabolism. The model is verified using standard cross‐validation procedures, and through its ability to carry out hepatic metabolic functions. The model's flux predictions correlate with flux measurements across a variety of hormonal and dietary conditions, and improve upon the predictive performance obtained using the original, generic human model (prediction accuracy of 0.67 versus 0.46). Finally, the model better predicts biomarker changes in genetic metabolic disorders than the generic human model (accuracy of 0.67 versus 0.59). The approach presented can be used to construct other human tissue‐specific models, and be applied to other organisms.

[1]  B. Hess,et al.  METABOLIC CONTROL MECHANISMS. VII.A DETAILED COMPUTER MODEL OF THE GLYCOLYTIC PATHWAY IN ASCITES CELLS. , 1964, The Journal of biological chemistry.

[2]  The circadian change of gluconeogenesis in the liver in vivo in fed rats. , 1980, Journal of biochemistry.

[3]  B. Fleshler,et al.  The Liver: Biology and Pathobiology , 1983 .

[4]  Sareen S. Gropper,et al.  Advanced Nutrition and Human Metabolism , 1990 .

[5]  Hepatic metabolism and disposition of endo- and xenobiotics : proceedings of the 57th Falk Symposium held in Freiburg-im-Breisgau, Germany, October 8-10, 1990 , 1991 .

[6]  R. Gebhardt.  Metabolic zonation of the liver: regulation and implications for liver function. , 1992, Pharmacology & therapeutics.

[7]  V. Dixit,et al.  The bioartificial liver: state-of-the-art. , 2003, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[8]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[9]  J. Gerlach,et al.  Treatment of acute liver failure: hybrid liver support , 1999, Langenbeck's Archives of Surgery.

[10]  D. Hess,et al.  Extracorporeal tissue engineered liver-assist devices. , 2000, Annual review of biomedical engineering.

[11]  J. Ijzermans,et al.  Extracorporeal perfusion for the treatment of acute liver failure. , 2000, Annals of surgery.

[12]  A. Beaudet,et al.  In vivo urea cycle flux distinguishes and correlates with phenotypic severity in disorders of the urea cycle. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  B. Palsson,et al.  In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data , 2001, Nature Biotechnology.

[14]  M. L. de la Mata,et al.  Bioartificial liver support. , 2001, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[15]  A Geerts,et al.  History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells , 2001, Seminars in liver disease.

[16]  Bernhard O Palsson,et al.  Extreme pathway analysis of human red blood cell metabolism. , 2002, Biophysical journal.

[17]  M. Lazar,et al.  A futile metabolic cycle activated in adipocytes by antidiabetic agents , 2002, Nature Medicine.

[18]  G. Church,et al.  Analysis of optimality in natural and perturbed metabolic networks , 2002 .

[19]  J. Neuberger,et al.  A Bioartificial Liver--State of the Art , 2002, Science.

[20]  Kyongbum Lee,et al.  Metabolic flux analysis of cultured hepatocytes exposed to plasma , 2003, Biotechnology and bioengineering.

[21]  Georgios Palaiologos,et al.  Metabolic flux analysis as a tool for the elucidation of the metabolism of neurotransmitter glutamate. , 2003, Metabolic engineering.

[22]  R. Mahadevan,et al.  The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. , 2003, Metabolic engineering.

[23]  J. Iredale.  Cirrhosis: new research provides a basis for rational and targeted treatments , 2003, BMJ : British Medical Journal.

[24]  Doron Lancet,et al.  GeneNote: whole genome expression profiles in normal human tissues. , 2003, Comptes rendus biologies.

[25]  B. Palsson,et al.  Uniform sampling of steady-state flux spaces: means to design experiments and to interpret enzymopathies. , 2004, Biophysical journal.

[26]  P. Karp,et al.  Computational prediction of human metabolic pathways from the complete human genome , 2004, Genome Biology.

[27]  D. Kell,et al.  Metabolomics by numbers: acquiring and understanding global metabolite data. , 2004, Trends in biotechnology.

[28]  Harvey J. Greenberg,et al.  Reconstruction and Functional Characterization of the Human Mitochondrial Metabolic Network Based on Proteomic and Biochemical Data* , 2004, Journal of Biological Chemistry.

[29]  Fuchu He,et al.  Human Liver Proteome Project , 2005, Molecular & Cellular Proteomics.

[30]  Doron Lancet,et al.  Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification , 2005, Bioinform..

[31]  Ricard V Solé,et al.  Topology, tinkering and evolution of the human transcription factor network , 2005, The FEBS journal.

[32]  Stefan R. Henz,et al.  A gene expression map of Arabidopsis thaliana development , 2005, Nature Genetics.

[33]  L. Nielsen,et al.  Modeling Hybridoma Cell Metabolism Using a Generic Genome‐Scale Metabolic Model of Mus musculus , 2008, Biotechnology progress.

[34]  E. Ruppin,et al.  Regulatory on/off minimization of metabolic flux changes after genetic perturbations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  L. Diehl,et al.  CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens , 2006, Cell.

[36]  Erwin P. Gianchandani,et al.  Flux balance analysis in the era of metabolomics , 2006, Briefings Bioinform..

[37]  Milton H. Saier,et al.  TCDB: the Transporter Classification Database for membrane transport protein analyses and information , 2005, Nucleic Acids Res..

[38]  Neil Kaplowitz,et al.  Liver biology and pathobiology , 2006, Hepatology.

[39]  B. Palsson.  Systems Biology: Properties of Reconstructed Networks , 2006 .

[40]  V. McKusick.  Mendelian Inheritance in Man and Its Online Version, OMIM , 2007, The American Journal of Human Genetics.

[41]  Michael L. Creech,et al.  Integration of biological networks and gene expression data using Cytoscape , 2007, Nature Protocols.

[42]  Ying Zhang,et al.  HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..

[43]  O. Demin,et al.  The Edinburgh human metabolic network reconstruction and its functional analysis , 2007, Molecular systems biology.

[44]  S Gail Eckhardt,et al.  NMR-based metabolomics: translational application and treatment of cancer. , 2007, Current opinion in molecular therapeutics.

[45]  Monica L. Mo,et al.  Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.

[46]  V. Dhawan,et al.  Changes in network activity with the progression of Parkinson's disease. , 2007, Brain : a journal of neurology.

[47]  Lake-Ee Quek,et al.  On the reconstruction of the Mus musculus genome-scale metabolic network model. , 2008, Genome informatics. International Conference on Genome Informatics.

[48]  Qing Yan,et al.  Human membrane transporter database: A web-accessible relational database for drug transport studies and pharmacogenomics , 2000, AAPS PharmSci.

[49]  Markus J. Herrgård,et al.  Network-based prediction of human tissue-specific metabolism , 2008, Nature Biotechnology.

[50]  Adam M. Feist,et al.  The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli , 2008, Nature Biotechnology.

[51]  C. Galmarini,et al.  Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy. , 2008, Current medicinal chemistry.

[52]  Jason A. Papin,et al.  Applications of genome-scale metabolic reconstructions , 2009, Molecular systems biology.

[53]  E. Ruppin,et al.  Predicting metabolic biomarkers of human inborn errors of metabolism , 2009, Molecular systems biology.

[54]  Vinay Satish Kumar,et al.  GrowMatch: An Automated Method for Reconciling In Silico/In Vivo Growth Predictions , 2009, PLoS Comput. Biol..

[55]  D. Fell,et al.  A Genome-Scale Metabolic Model of Arabidopsis and Some of Its Properties1[C][W] , 2009, Plant Physiology.

[56]  John Parkinson,et al.  The conservation and evolutionary modularity of metabolism , 2009, Genome Biology.

[57]  P. May,et al.  An integrative approach towards completing genome-scale metabolic networks. , 2009, Molecular bioSystems.

[58]  M. Ierapetritou,et al.  A Rational Design Approach for Amino Acid Supplementation in Hepatocyte Culture , 2009 .

[59]  Manal AbuOun,et al.  Genome Scale Reconstruction of a Salmonella Metabolic Model , 2009, The Journal of Biological Chemistry.

[60]  Jan Schellenberger,et al.  Use of Randomized Sampling for Analysis of Metabolic Networks* , 2009, Journal of Biological Chemistry.

[61]  V. Schachter,et al.  Genome-scale models of bacterial metabolism: reconstruction and applications , 2008, FEMS microbiology reviews.

[62]  Jeffrey D Orth,et al.  What is flux balance analysis? , 2010, Nature Biotechnology.

[63]  E. Ruppin,et al.  Predicting selective drug targets in cancer through metabolic networks , 2011, Molecular systems biology.

[64]  Elaine Holmes,et al.  The application of NMR-based metabonomics in neurological disorders , 2006, NeuroRX.